Evidence map›Paper›PMID 29295555›Full record

ArticleInternational journal of molecular sciences2017

Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.

Sabrina Angelini, Martina Rosticci, Gianmichele Massimo, Muriel Musti, Gloria Ravegnini, Nicola Consolini, Giulia Sammarini, Sergio D'Addato, Elisabetta Rizzoli, Dauren Botbayev and 4 more

Open access · goldFull text read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Association ofPeerJ · 2024
    Article
  4. New Perspectives on Cholesterol and Lipoprotein Metabolism.International journal of molecular sciences · 2023
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Personalized rosuvastatin therapy in problem patients with partial statin intolerance.Archives of medical sciences. Atherosclerotic diseases · 2018
    Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Sabrina AngeliniDepartment of Pharmacy and Biotechnology, via Irnerio 48, University of Bologna, 40126 Bologna, Italy. s.angelini@unibo.it.ORCID 0000-0002-1609-0421
Martina RosticciDepartment of Medical and Surgical, University of Bologna, 40126 Bologna, Italy. mrosticci@yahoo.com.
Gianmichele MassimoDepartment of Pharmacy and Biotechnology, via Irnerio 48, University of Bologna, 40126 Bologna, Italy. gianmichele.massimo3@unibo.it.ORCID 0000-0001-9461-9629
Muriel MustiDepartment of Public Health, Epidemiological Service, Local Health Authority of Bologna, 40126 Bologna, Italy. m.musti@ausl.bologna.it.
Gloria RavegniniDepartment of Pharmacy and Biotechnology, via Irnerio 48, University of Bologna, 40126 Bologna, Italy. gloria.ravegnini2@unibo.it.
Nicola ConsoliniDepartment of Pharmacy and Biotechnology, via Irnerio 48, University of Bologna, 40126 Bologna, Italy. nicola.consolini2@unibo.it.
Giulia SammariniDepartment of Pharmacy and Biotechnology, via Irnerio 48, University of Bologna, 40126 Bologna, Italy. giulia.sammarini2@unibo.it.
Sergio D'AddatoDepartment of Medical and Surgical, University of Bologna, 40126 Bologna, Italy. sergio.daddato@unibo.it.ORCID 0000-0001-6631-4342
Elisabetta RizzoliDepartment of Medical and Surgical, University of Bologna, 40126 Bologna, Italy. elisabetta.rizzoli@unibo.it.
Dauren BotbayevDepartment of Pharmacy and Biotechnology, via Irnerio 48, University of Bologna, 40126 Bologna, Italy. daur_92_05@bk.ru.
Claudio BorghiDepartment of Medical and Surgical, University of Bologna, 40126 Bologna, Italy. claudio.borghi@unibo.it.
Giorgio Cantelli-FortiDepartment for Life Quality Studies, Corso d'Augusto 237, University of Bologna, 47921 Rimini, Italy. giorgio.cantelliforti@unibo.it.
Arrigo F CiceroDepartment of Medical and Surgical, University of Bologna, 40126 Bologna, Italy. arrigo.cicero@unibo.it.ORCID 0000-0002-4367-3884
Patrizia HreliaDepartment of Pharmacy and Biotechnology, via Irnerio 48, University of Bologna, 40126 Bologna, Italy. patrizia.hrelia@unibo.it.
University of Bologna · ITAl-Farabi Kazakh National University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The existence of genetic traits might explain the susceptibility to develop hypercholesterolemia and the inter-individual differences in statin response. This study was performed to evaluate whether individuals' polymorphisms in

Indexed as

Acyl Coenzyme AAdultAgedAged, 80 and overBody Mass IndexDemographyFemaleGenetic LociGenetic Predisposition to DiseaseGenotypeHumansHydroxymethylglutaryl-CoA Reductase InhibitorsKinesinsLipidsMaleMiddle Aged3-hydroxy-3-methylglutaryl-coenzyme AAcyl Coenzyme AHydroxymethylglutaryl-CoA Reductase InhibitorsKIF6 protein, humanKinesinsLipidsBrisighella heart studyHMG-CoAhypercholesterolemiaKIF6polymorphismswaist circumference

Identifiers

PMID29295555
PMCPMC5795999
OpenAlexW2779959629

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.